AthernoNova, Maxwell Biotech preclinical data

In a mouse model of atherosclerosis, AHRO-001 plus chow for 15 weeks reduced fasting plasma glucose (FPG) levels by 37% vs. chow alone. AHRO-001 plus chow also significantly reduced atherosclerotic le...